Receives Foundational Patent For Its Oral Pth Using Its Platform Oral Protein Delivery Technology In European Union
17/06/2021 13:03
June 17 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO LTD - RECEIVES FOUNDATIONAL PATENT FOR ITS ORAL
PTH
USING ITS PLATFORM ORAL PROTEIN DELIVERY TECHNOLOGY IN EUROPEAN
UNION
Source text for Eikon: ID:nGNX4xQRsl
Further company coverage: 5DT.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement